Ticker Short Interest

BMRN Short Interest Intelligence

Biomarin Pharmaceutical Inc positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 14 Aug 2026 Neutral

Neutral

Covering Rally

BMRN is classified as Neutral. Latest reported short interest is 10.2M shares; short interest changed -18.4%, price moved +12.2% since the previous report, short interest is in the 30th percentile, and days to cover is in the 10th percentile. Trend context is constructive.

Setup Score49/100Neutral
Reported Short Interest10.2M-18.4% vs prior report
Days To Cover3.6910.00 percentile
Price Reaction+12.2%since previous short report
Squeeze Pressure42crowding, trend, and pressure
Bearish Conviction9shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-08-14

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-08-14

Squeeze Radar

42

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

9

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

21

Latest short interest is 10.2M shares and days to cover is 3.69.

Divergence

0

Short interest fell while price rose. The bearish trade appears to be unwinding into strength.

Report History

BMRN Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
14 Aug 2026 10202950 12504131 -18.4% 3.69 2767411
31 Jul 2026 12504131 14315984 -12.7% 7.42 1684263
15 Jul 2026 14315984 13908847 2.9% 10.16 1409304
30 Jun 2026 13908847 12516448 11.1% 6.04 2301848
15 Jun 2026 12516448 11605279 7.9% 6.06 2066601
29 May 2026 11605279 11359229 2.2% 3.97 2921395
15 May 2026 11359229 10792859 5.3% 5.42 2096087
30 Apr 2026 10792859 10151216 6.3% 7.28 1482676
15 Apr 2026 10151216 8832493 14.9% 6.42 1581415
31 Mar 2026 8832493 8501110 3.9% 4.20 2100926

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.

Evidence context